The stock market is well past that period where almost anything
China-related became an overnight sensation. That said, there are some
powerful realities about the size of the Chinese economy and the
opportunities in areas like healthcare. That brings us to the
opportunity in Mindray Medical (MR).
Mindray is one of the very few Chinese med-tech companies to have a
legitimate business outside of China, as well as extensive growth
opportunities within China. Margins, domestic competition, and an
uncertain strategy in the U.S. are all valid reasons for concern, but
Mindray just may be one of the better growth opportunities in med-tech
right now.
Please read the full article here:
Skepticism About Mindray In America Overlooks Opportunities In China
No comments:
Post a Comment